The TGA will be conducting targeted compliance reviews of selected listed medicines that contain colecalciferol (Vitamin D) and bone related indications, beginning Oct/Nov 2022. The review does not include review of products that contain vitamin D and calcium.
This technical alert provides more information for sponsors, including additional contextual information on studies that may have informed the review, and comparable international perspectives.